Do you need Prime for Amazon's October sale? Here's what to know

Amazon's ‘Prime Big Deal Days' sale goes live on October 6th and 7th. We've broken down whether you need an active Amazon ...
Pharmabiz

Lilly's Olumiant receives US FDA approval for paediatric patients 12 years of age and older with severe alopecia areata

Lilly's Olumiant receives US FDA approval for paediatric patients 12 years of age and older with severe alopecia areata: Indianapolis Monday, September 28, 2026, 16:00 Hrs [IST] E ...
MarketScreener

FDA approves Lilly's Olumiant for pediatric patients 12 years of age and older with severe alopecia areata

INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration ( FDA) approved Olumiant (baricitinib), a once-daily pill, for the treatment of pediatric patients ...

The North Face Commuting & School Item Complete Guide | Choosing Models for Adults

"The North Face = outdoor or for young people"—there are still a surprisingly large number of people who stop at this ...

Eli Lilly and Company: FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata

PEDS, the first and largest Phase 3 study specifically designed to evaluate pediatric patients with severe alopecia areata ...
El Cronista

Health supplements: 8 out of 10 Americans take them, and older adults are the ones who choose them most

The results showed that adults over 65 are the ones who take the most supplements: of the respondents who are older than this ...
BioSpace

FDA approves Lilly’s Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata

PEDS, the first and largest Phase 3 study specifically designed to evaluate pediatric patients with severe alopecia areata ...
Dermatology Times

FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata

Baricitinib (Olumiant) is FDA-approved for pediatric patients 12 years of age and older with severe alopecia areata, in ...

LSU doctors warn of hard-to-detect designer opioid

An unregulated designer opioid called cychlorphine has been identified across several parishes in north Louisiana, posing significant health risks due to its difficulty to detect and potential ...
AllAfrica

Zimbabwe: HIV Injections Every Eight Weeks More Effective Than Daily Pills for Adolescents - Study

Young people living with HIV manage the virus better when they receive antiretroviral therapy through injections every eight weeks rather than taking daily tablets, a UCL-led study has found.

Don't let it end with 'Ask AI.' 5 family habits to nurture a child's 'ability to think for themselves'

Thank you for all your hard work in raising your children every day.I was startled when I saw a certain poster.The other day, among the materials my child brought home from school, I saw an ...